ATE323706T1 - Pyrazolopyridazinderivate - Google Patents

Pyrazolopyridazinderivate

Info

Publication number
ATE323706T1
ATE323706T1 AT02805104T AT02805104T ATE323706T1 AT E323706 T1 ATE323706 T1 AT E323706T1 AT 02805104 T AT02805104 T AT 02805104T AT 02805104 T AT02805104 T AT 02805104T AT E323706 T1 ATE323706 T1 AT E323706T1
Authority
AT
Austria
Prior art keywords
pyrazolopyridazine derivatives
pyrazolopyridazine
derivatives
Prior art date
Application number
AT02805104T
Other languages
English (en)
Inventor
Phillip Anthony Harris
David Kendall Jung
Michael Robert Peel
Michael John Reno
Tara Renae Rheault
Jennifer G Badiang
Kirk Lawrence Stevens
James Marvin Veal
Francis Xavier Tavares
Scott Howard Dickerson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE323706T1 publication Critical patent/ATE323706T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02805104T 2001-12-17 2002-12-11 Pyrazolopyridazinderivate ATE323706T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34179801P 2001-12-17 2001-12-17

Publications (1)

Publication Number Publication Date
ATE323706T1 true ATE323706T1 (de) 2006-05-15

Family

ID=23339081

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02805104T ATE323706T1 (de) 2001-12-17 2002-12-11 Pyrazolopyridazinderivate

Country Status (10)

Country Link
US (1) US7279473B2 (de)
EP (1) EP1463730B1 (de)
JP (1) JP2005524609A (de)
AR (1) AR037826A1 (de)
AT (1) ATE323706T1 (de)
AU (1) AU2002357164A1 (de)
DE (1) DE60210819T2 (de)
ES (1) ES2262899T3 (de)
TW (1) TW200301119A (de)
WO (1) WO2003051886A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2251677T3 (es) 2002-01-22 2006-05-01 Warner-Lambert Company Llc 2-(piridin-2-ilamino)-pirido(2,3-d)pirimidin-7-onas.
EP1551842A1 (de) * 2002-10-15 2005-07-13 Smithkline Beecham Corporation Pyridazinverbindungen als gsk-3-inhibitoren
ATE412650T1 (de) * 2003-07-11 2008-11-15 Warner Lambert Co Isethionat salz eines selektiven cdk4 inhibitors
DE10344223A1 (de) * 2003-09-24 2005-04-21 Merck Patent Gmbh 1,3-Benzoxazolylderivate als Kinase-Inhibitoren
US7855205B2 (en) 2004-10-29 2010-12-21 Janssen Pharmaceutica Nv Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
US7709468B2 (en) 2005-09-02 2010-05-04 Abbott Laboratories Imidazo based heterocycles
CN101547917A (zh) * 2006-12-08 2009-09-30 霍夫曼-拉罗奇有限公司 用作jnk调节剂的取代的嘧啶类化合物及它们的应用
CA2707989A1 (en) 2007-12-07 2009-06-11 Novartis Ag Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases
US8309566B2 (en) 2008-02-15 2012-11-13 Rigel Pharmaceuticals, Inc. Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
CN102137672B (zh) * 2008-06-30 2014-03-26 詹森药业有限公司 取代的嘧啶衍生物的制备方法
AR074870A1 (es) * 2008-12-24 2011-02-16 Palau Pharma Sa Derivados de pirazolo (1,5-a ) piridina
JP5959537B2 (ja) * 2011-01-28 2016-08-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換ピリジニル−ピリミジン及び医薬としてのその使用
US20150203812A1 (en) * 2014-01-20 2015-07-23 Francesco Tombola Inhibitors of Voltage Gated Ion Channels
GB201605126D0 (en) * 2016-03-24 2016-05-11 Univ Nottingham Inhibitors and their uses
CN106699608A (zh) * 2016-12-26 2017-05-24 常州大学 一种含有强吸电子基团的苯胍及其盐的制备方法
GB201715342D0 (en) * 2017-09-22 2017-11-08 Univ Nottingham Compounds
US11066404B2 (en) 2018-10-11 2021-07-20 Incyte Corporation Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
WO2020168197A1 (en) 2019-02-15 2020-08-20 Incyte Corporation Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors
WO2020180959A1 (en) 2019-03-05 2020-09-10 Incyte Corporation Pyrazolyl pyrimidinylamine compounds as cdk2 inhibitors
WO2020205560A1 (en) 2019-03-29 2020-10-08 Incyte Corporation Sulfonylamide compounds as cdk2 inhibitors
US11440914B2 (en) 2019-05-01 2022-09-13 Incyte Corporation Tricyclic amine compounds as CDK2 inhibitors
WO2020223558A1 (en) 2019-05-01 2020-11-05 Incyte Corporation Tricyclic amine compounds as cdk2 inhibitors
CN114269742B (zh) * 2019-07-10 2024-07-16 常州千红生化制药股份有限公司 作为治疗剂的4-(咪唑并[1,2-a]吡啶-3-基)-N-(吡啶基)嘧啶-2-胺的衍生物
TW202115024A (zh) 2019-08-14 2021-04-16 美商英塞特公司 作為cdk2 抑制劑之咪唑基嘧啶基胺化合物
AU2020364007A1 (en) 2019-10-11 2022-04-28 Incyte Corporation Bicyclic amines as CDK2 inhibitors
US11981671B2 (en) 2021-06-21 2024-05-14 Incyte Corporation Bicyclic pyrazolyl amines as CDK2 inhibitors
US11976073B2 (en) 2021-12-10 2024-05-07 Incyte Corporation Bicyclic amines as CDK2 inhibitors
WO2023107705A1 (en) 2021-12-10 2023-06-15 Incyte Corporation Bicyclic amines as cdk12 inhibitors
CN118005948B (zh) * 2024-04-09 2024-06-28 蓝固(湖州)新能源科技有限公司 一种电解液添加剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU622330B2 (en) 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
CA2291709A1 (en) * 1997-05-30 1998-12-03 Merck & Co., Inc. Novel angiogenesis inhibitors
ES2256817T3 (es) * 1997-09-05 2006-07-16 Glaxo Group Limited Composiciones farmaceuticas que comprenden derivados de 2,3-diaril-pirazolo(1,5-b)piridazina.
AU3352899A (en) 1997-12-11 1999-07-12 American Home Products Corporation 2,4,6-trisubstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof
GB9919778D0 (en) * 1999-08-21 1999-10-27 Zeneca Ltd Chemical compounds
DE60018037T2 (de) 1999-11-10 2006-01-12 Ortho-Mcneil Pharmaceutical, Inc. Substituierte 2-aryl-3-(heteroaryl)-imidazo[1,2-alpha]pyrimidine und ihren verwandten arzneimittel und verfahren
EP1317450B1 (de) 2000-09-15 2006-11-22 Vertex Pharmaceuticals Incorporated Pyrazolverbindungen als protein-kinasehemmer
GB0103926D0 (en) 2001-02-17 2001-04-04 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
EP1463730B1 (de) 2006-04-19
DE60210819D1 (en) 2006-05-24
US20050090507A1 (en) 2005-04-28
US7279473B2 (en) 2007-10-09
WO2003051886A1 (en) 2003-06-26
AU2002357164A1 (en) 2003-06-30
ES2262899T3 (es) 2006-12-01
WO2003051886A8 (en) 2004-08-19
TW200301119A (en) 2003-07-01
JP2005524609A (ja) 2005-08-18
AU2002357164A8 (en) 2003-06-30
DE60210819T2 (de) 2007-04-19
EP1463730A1 (de) 2004-10-06
AR037826A1 (es) 2004-12-09

Similar Documents

Publication Publication Date Title
ATE323706T1 (de) Pyrazolopyridazinderivate
ATE319451T1 (de) Tetrahydrochinolin-derivate
DE60235777D1 (de) Verschleissanordnung
DE50204184D1 (de) Espressobrüheinrichtung
DE60226770D1 (de) Verkokungskammerentleerungssystem
DE60116518D1 (de) Mehrzweckbohrwagen
DE60212419D1 (de) Kontaktmetathesepolymerisation
ATE312827T1 (de) 3-substituierte-4-pyrimidonderivate
NO20014084L (no) Dypbrönnsinstrumentering
DE50206021D1 (de) Schlauchklemme
DE60205841D1 (de) Perfluoroelastomere
DE60202533D1 (de) Verschlusskappe
DE60213841D1 (de) Hydrazono-malonitrile
EP1433140A4 (de) Chromatinsegmentierung
DE50208372D1 (de) Schrankaufhängevorrichtung
DE50211290D1 (de) Handzange
DE60217846D1 (de) Mastnutzlastandockstation
EP1572867A4 (de) Endothelzellexpressionsmuster
DE60223031D1 (de) Arylpiperazin gebundene tetrahydroindolonderivate
DE50208029D1 (de) Kugelgelenk
DE60233454D1 (de) Wirbelstromprüfsonde
DE60206350D1 (de) Ozonisator
DK1395583T3 (da) Phenylpiperaziner
DE60202381D1 (de) Paroxetin-n-formyl-derivate
FR2829907B1 (fr) Yaourtiere menagere

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties